Following fields are empty!
Welcome to the University of Turku Journal Guide
The Journal Guide gives you peace of mind when selecting journals. If you are a researcher from the University of Turku you can look up your favorite journals or search and filter to get to a selection of journals that match your research. Select a funder to see whether the journals are compliant or not, and check the filter ‘Journals with agreements’ to limit the list to journals for which the APCs are fully or partially waived.
Clinical Lung Cancer
Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
Clinical Lymphoma
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Lymphoma & Myeloma
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Lymphoma, Myeloma and Leukemia
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our
Please see our
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä. Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access. Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
Clinical Lymphoma, Myeloma and Leukemia
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medical Image Library
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medical Reviews and Case Reports
Clinical Medical Reviews and Case Reports (CMRCR) is an open access monthly journal publishing Cases, Reviews and Images to elaborate the importance of solving case challenges. The Journal allows clinical and medical reviews among elaborated fields such as Angiology/Vascular Medicine, Cardiology, Critical care medicine, Otolaryngology, Rhinology, Tumor Science, Ophthalmology, Dentistry, Endocrinology, Gastroenterology, Geriatrics, Hematology, Hepatology, Infectious diseases, Nephrology, Neurology, Oncology, Pathology, Pediatrics, Gynecology, Cytology, Andrology, Pulmonology, Rheumatology, etc. from scholarly open accessed attributes. This Journal focus upon building a thorough network among the doctors to understand the cases and provide improvised medical care and discuss further advancements in treating the challenging cases.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medicine
The Royal College of Physicians (RCP) has been supporting and representing physicians for nearly 500 years. Our roots stretch back to Henry VIII, but our members today work in the fast-paced, ever-changing, highly technological world of medicine.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita sopimuskauden 2026 aikana 15 %:n alennuksella gold open access -lehtien APC-maksuista. Jos haluat hoitaa gold open access –lehdissä julkaistavien artikkelien maksuliikenteen rahoituksen yliopiston talouden kautta, liitä APC-pyyntöön talouspalvelujen ohjeistuksen mukaiset laskutustiedot: oikea laskutusosoite ja laskulle oikea maksuviite. Katso ohjeita intranetin sivulta.-
Huom! Koska avoimia artikkeleita on käytettävissä rajallinen määrä, on mahdollista, että artikkelikiintiö loppuu elo-syyskuun 2026 aikana, jonka jälkeen hyväksyttyjä artikkeleita ei välttämättä voida avata osana FinELib-sopimusta.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals
Under the FinELib consortium’s agreement with Elsevier, corresponding authors can publish their articles during the year 2026 with 15% discount of the journal’s APC in Elsevier gold open access journals. If you need to take care of the payment transactions through financial services of the university, please, add to your APC request invoicing information according to instructions of the financial services: correct invoicing address and reference. You can find instructions at intranet.
-
Att! Since there is a limited number of free open access articles available it is possible that the article quota is exhausted in August or September 2026.
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena maksutta SAGEn hybridilehdissä ja 27:ssa Full OA -lehdessä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating insitutions to publish their articles open access free of charge in Sage hybrid journals and in 27 Full OA journals. The number of articles is unlimited. OA publishing without extra charge applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Clinical Medicine Insights: Blood Disorders
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medicine Insights: Cardiology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena 20% alennuksella APC-maksuista SAGEn avoimissa gold OA-lehdissä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating institutions to publish their articles open access with 20% discount of the journal’s APC (Article Processing Charge) in Sage gold open access journals. The number of articles is unlimited. OA publishing with discount applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Clinical Medicine Insights: Case Reports
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena 20% alennuksella APC-maksuista SAGEn avoimissa gold OA-lehdissä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating institutions to publish their articles open access with 20% discount of the journal’s APC (Article Processing Charge) in Sage gold open access journals. The number of articles is unlimited. OA publishing with discount applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Clinical Medicine Insights: Ear, Nose and Throat
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medicine Insights: Endocrinology and Diabetes
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena 20% alennuksella APC-maksuista SAGEn avoimissa gold OA-lehdissä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating institutions to publish their articles open access with 20% discount of the journal’s APC (Article Processing Charge) in Sage gold open access journals. The number of articles is unlimited. OA publishing with discount applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Clinical Medicine Insights: Geriatrics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medicine Insights: Oncology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena 20% alennuksella APC-maksuista SAGEn avoimissa gold OA-lehdissä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating institutions to publish their articles open access with 20% discount of the journal’s APC (Article Processing Charge) in Sage gold open access journals. The number of articles is unlimited. OA publishing with discount applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Clinical Medicine Insights: Pathology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medicine Insights: Pediatrics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion ja SAGEn välinen sopimus takaa Turun yliopiston henkilökunnalle ja opiskelijoille mahdollisuuden julkaista artikkelinsa avoimena maksutta SAGEn hybridilehdissä ja 27:ssa Full OA -lehdessä. Julkaisuoikeus on rajoittamaton ja koskee vastaavia kirjoittajia. Ohjeita julkaisemiseen FinELibin sivuilla: https://finelib.fi/oa-julkaiseminen-sagen-lehdissa/ The agreement between FinELib consortium and SAGE contains the possibility for the researchers of the participating insitutions to publish their articles open access free of charge in Sage hybrid journals and in 27 Full OA journals. The number of articles is unlimited. OA publishing without extra charge applies to corresponding authors. Instructions on publishing on FinELib's pages: https://finelib.fi/open-access-publishing-in-sage-journals/Clinical Medicine Insights: Psychiatry
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Clinical Medicine Insights: Therapeutics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.